El Enfoque Actual de la Cuarentena es Incorrecto Basado en la Ciencia: Abran la Sociedad Ahora, dicen el Dr. Dan Erickson y el Dr. Artin Massihi.

Current Quarantine Approach Wrong Based on Science: Open Up Society Now | Dr. Dan Erickson and Dr. Artin Massihi

CENSURADO POR YOUTUBE:

Resumen informativo de COVID-19: El Enfoque Actual de la Cuarentena es Incorrecto Basado en la Ciencia: Abran la Sociedad Ahora, dicen el Dr. Dan Erickson y el Dr. Artin Massihi

#NoTeQuedesEnCasa #SalATrabajar

[Thompson et al., 2009] W.W. Thompson, E. Weintraub, P. Dhankhar, P.-Y. Cheng, L. Brammer, M.I. Meltzer, J.S. Bresee, D.K. Shay. Estimates of US Influenza-Associated Deaths Made Using Four Different Methods. Influenza and Other Respiratory Viruses, Vol. 3, Issue 1, January 2009, pp. 37–49.
sci-hub.twwww.ncbi.nlm.nih.gov/pubmed/19453440

Roussel et al. SARS-CoV-2: Fear Versus Data. Int. J. Antimicrob. Agents 2020, 105947; www.sciencedirect.com/…/S09248579203009…

Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., … Raoult, D. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, 105949.
www.sciencedirect.com/…/S09248579203009…

www.cdc.gov/flu/about/burden/index.html

Principles of Virology, 2015
J Flint, V Racaniello, G Rall, A M Skalka
ia801000.us.archive.org/…/J Flint, V Raca…

PARA CORRECCIÓN DE LA PERSPECTIVA EVOLUCIONISTA:

The Flu: Everything You Need to Know
answersingenesis.org/…/flu-everything-…

COVID-19, Coronavirus, and Creation Virology
answersingenesis.org/…/covid19-coronav…

[Brown, 2008] Walt Brown, Ph.D. In the Beginning: Compelling Evidence for Creation and the Flood. Center for Scientific Creation, 8th edition. China, 2008
drive.google.com/…/view

PARA USAR UNA CORRECTA TEOLOGÍA:

[Faria, 1950] Pbro. J. R. Faria. Curso Superior de Religión: Dogma – Moral – Culto – Apologética. Editorial Voluntad LTDA, Decima Primera Edición. Bogotá, Colombia, 1950.
drive.google.com/…/view

MÁS REFERENCIAS BIBLIOGRÁFICAS

...the finding itself (of COVID-19) has no clinical significance. It is just another name for acute respiratory illnesses (ARI), which as every year put 30% to 70% of all people in our countries more or less out of action for a week or two every winter.

According to a prospective ARI-virus monitoring in Scotland from 2005 to 2013, the most common pathogens of acute respiratory diseases were: 1. rhinoviruses, 2. influenza A viruses, 3. influenza B viruses, 4. RS viruses and 5. coronaviruses.

This order changed slightly from year to year. Even with viruses competing for our mucous membrane cells, there is apparently a changing quorum, as we know it from our intestines in the case of microorganisms and from the Bundestag in the case of political groups.

[Nickbakhsh et al., 2019] S. Nickbakhsh, C. Mair, L. Matthews, R. Reeve, P.C.D. Johnson, F. Thorburn, B. Wissmann, A. Reynolds, J. McMenamin, R.N. Gunson, P.R. Murcia. Virus–virus interactions impact the population dynamics of influenza and the common cold. Proceedings of the National Academy of Sciences of the United States of America (PNAS), December 2019, Vol. 116, No. 52, pp. 27142-27150.
www.pnas.org/…/27142.full.pdf

[CDC, 2019] Centers for Disease Control and Prevention (CDC). Estimated Influenza Disease Burden, by Season United States, 2010-11 through 2017-18 Influenza Seasons.
www.cdc.gov/…/printable-table…

[Roussel et al., 2020] Y. Roussel, A. Giraud-Gatineau, M.T. Jimeno, J.M. Rolain, C. Zandotti, P. Colson, D. Raoult. SARS-CoV-2: fear versus data. International Journal of Antimicrobial Agents, March 2020, 105947.
www.sciencedirect.com/…/pdfft

[Li et al., 2020] Y. Li, L. Yao, J. Li, L. Chen, Y. Song, Z. Cai, C. Yang. Stability issues of RT‐PCR testing of SARS‐CoV‐2 forhospitalized patients clinically diagnosed with COVID‐19. Journal of Medical Virology. March 2020, Wiley Periodicals, Inc., pp. 1–6.
onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.25786

[RKI, 2019] Robert Koch-Institut (RKI), Berlin, 2019. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2018. ISBN: 978-3-89606-297-0, 2019
www.rki.de/…/Jahrbuch_2018.p…

[Thompson et al., 2009] W.W. Thompson, E. Weintraub, P. Dhankhar, P.-Y. Cheng, L. Brammer, M.I. Meltzer, J.S. Bresee, D.K. Shay. Estimates of US Influenza-Associated Deaths Made Using Four Different Methods. Influenza and Other Respiratory Viruses, Vol. 3, Issue 1, January 2009, pp. 37–49.
sci-hub.twwww.ncbi.nlm.nih.gov/pubmed/19453440

[López et al., 2012] T.López, S. Mateo, S. Jiménez, C. Savulescu, A. Larrauri. Influenza-related mortality in Spain, 1999-2005. Gaceta Sanitaria, August 2012, Vol. 26, Issue 4, pp. 325–329.
www.sciencedirect.com/…/pdfft

[Colson et al., 2020] P. Colson, J.M. Rolain, J.C. Lagier, P. Brouqui, D. Raoult. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. International Journal of Antimicrobial Agents, Volume 55, Issue 4, April 2020, 105932.
www.sciencedirect.com/…/pdfft

[Gautret et al., 2020] P. Gautret, J.C. Lagier, P. Parola, V.T. Hoang, L. Meddeb, M. Mailhe, B. Doudier, J. Courjon, V. Giordanengo, V.E. Vieira, H.T. Dupont, S. Honoré, P. Colson, E. Chabrière, B. Scola, J.M. Rolain, P. Brouqui, D. Raoult. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, March 2020, 105949.
www.sciencedirect.com/…/pdfft

[Andreani et al., 2020] J. Andreani, M. Bideau, I. Duflot, P. Jardot, C. Rolland, M. Boxberger, N. Wurtz, J.M. Rolain, P. Colson, B. Scola, D. Raoult. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microbial Pathogenesis, Volume 145, April 2020, 104228.
www.sciencedirect.com/…/pdfft